China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
162 hedge funds and large institutions have $3.22B invested in China Biologic Products Holdings, Inc. in 2016 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 60 increasing their positions, 44 reducing their positions, and 18 closing their positions.
133% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 18
55% more capital invested
Capital invested by funds: $2.08B → $3.22B (+$1.15B)
36% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 44
17% more funds holding
Funds holding: 138 → 162 (+24)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
24% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $24.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$51.4M |
| 2 |
CCMH
Cornerstone Capital Management Holdings
New York
|
+$35.2M |
| 3 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
+$28.2M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.8M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Warburg Pincus
New York
|
-$154M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$60M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
-$31.5M |
| 4 |
SFM
Soros Fund Management
New York
|
-$25.2M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
-$14.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Daiwa Securities Group
Tokyo,
Japan
| – | -$53K | -500 | Closed |
|
177
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$45K | -425 | Closed |
|
178
Barclays
London,
United Kingdom
| – | -$44K | -417 | Closed |
|
|
CSS
179
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$40K | -378 | Closed |
|
|
QT
180
Quantbot Technologies
New York
| – | -$36K | -345 | Closed |
|
CBPO Hedge Fund Activity: Q3 2016 in Review
162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q3 2016, worth a combined $3.22B — up 55% from $2.08B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new CBPO positions and 18 closed out — a net gain of 24 holders — while 60 added to existing stakes and 44 trimmed.
The largest buyer was Fidelity International, adding an estimated $51.4M. The largest seller was Warburg Pincus, cutting an estimated $154M.
- 162 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q3 2016, up from 138 in Q2 2016.
- Funds reported $3.22B of China Biologic Products Holdings, Inc. stock for Q3 2016, up 55% quarter-over-quarter.
- 42 funds opened new China Biologic Products Holdings, Inc. positions in Q3 2016 and 18 closed out, a net change of +24 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q3 2016 was Fidelity International, an estimated $51.4M added.
- The largest China Biologic Products Holdings, Inc. seller in Q3 2016 was Warburg Pincus, an estimated $154M sold.
Based on aggregated 13F filings for Q3 2016.